Ralph Baric, PhD, on the Immune Responses to the NIH's Dengue Vaccine
01/13/2020
In this podcast, Ralph Baric, PhD, from the University of North Carolina at Chapel Hill, discusses his latest research on the National Institute of Health's dengue vaccine, what the findings mean for the future development of vaccines, and more.
Ralph S. Baric, PhD, is the William R. Kenan, Jr. Distinguished Professor in the department of epidemiology, a professor in the department of microbiology and immunology, and a member of the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill.
Additional Reading:
- Swanstrom JA, Nivarthi UK, Patel B, [Baric RS], et al. Beyond neutralizing antibody levels: the epitope specificity of antibodies induced by National Institutes of Health monovalent dengue virus vaccines. J Infect Dis. 2019;220(2):219-227. https://doi.org/10.1093/infdis/jiz109.
